Overview Financials News + Filings IR Vault Key Docs Charts Transactions Ownership Insiders
|
|
Emergent BioSolutions Inc. (EBS)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 42.3% | 33.7% | 39.2% | 41.2% | 33.5% | 25.8% | 22.0% | 25.2% |
| Gross profit | 57.7% | 66.3% | 60.8% | 58.8% | 66.5% | 74.2% | 78.0% | 74.8% |
| Selling, general and administrative | 19.4% | 19.5% | 24.7% | 25.9% | 25.5% | 29.3% | 24.8% | 26.8% |
| Research and development | 13.1% | 15.1% | 20.5% | 18.3% | 17.4% | 21.9% | 24.4% | 25.9% |
| EBITDA | 29.1% | 37.3% | 20.3% | 19.4% | 29.8% | 29.4% | 36.1% | 30.1% |
| Depreciation | 3.6% | 3.5% | 4.7% | 4.8% | 6.1% | 6.4% | 7.2% | 8.0% |
| EBITA | 25.4% | 33.8% | 15.6% | 14.7% | 23.7% | 23.0% | 28.9% | 22.1% |
| Amortization of intangibles | 3.3% | 3.8% | 5.3% | 3.2% | 1.5% | 1.4% | | |
| EBIT | 22.2% | 29.9% | 10.3% | 11.5% | 22.2% | 21.6% | 28.9% | 22.1% |
| Pre-tax income | 17.5% | 26.2% | 7.0% | 10.4% | 21.1% | 20.3% | 27.7% | 20.8% |
| Income taxes | 4.7% | 6.6% | 2.1% | 2.4% | 6.4% | 7.5% | 9.1% | 7.4% |
| Net income | 12.9% | 19.6% | 4.9% | 8.0% | 14.7% | 20.3% | 27.7% | 22.5% |
|